Today: 22 May 2026
PNC stock rises premarket as earnings beat fuels buyback focus
16 January 2026
2 mins read

PNC stock rises premarket as earnings beat fuels buyback focus

New York, Jan 16, 2026, 08:48 EST — Premarket

  • PNC shares gained roughly 1.5% in premarket trading following the bank’s Q4 profit beat.
  • Net interest income climbed 6%, while capital markets and advisory revenue soared 41%
  • At 9 a.m. EST, traders will scrutinize the call for clues on 2026 margin, credit, and buyback plans

Shares of PNC Financial Services Group gained 1.5% in premarket action Friday following a fourth-quarter earnings beat and an announcement of accelerated share buybacks. The stock was last indicated at $218.46.

The results come at a sensitive time for bank stocks, as investors search for clues that net interest income—the gap between what banks make on loans versus what they pay on deposits—can withstand rising funding costs. For PNC, the mix is crucial: straightforward banking on one hand, deal fees on the other.

PNC reported net income of $2.03 billion, or $4.88 per share, on record revenue of $6.07 billion for the quarter ending Dec. 31. Net interest income climbed to $3.73 billion, while the net interest margin—PNC’s lending spread—rose 5 basis points to 2.84%. “By virtually all measures, 2025 was a successful year,” said CEO Bill Demchak. The PNC Financial Services Group, Inc.

Fees played a key role in the boost. Capital markets and advisory revenue surged 41% to $489 million as global M&A activity topped $5 trillion in 2025, Reuters reported. PNC’s Harris Williams advised Warburg Pincus-backed TRC on its $3.3 billion sale to WSP Global. Despite that, PNC shares rose 8.2% in 2025, trailing the KBW Bank Index’s 28.8% gain, Reuters noted.

The bank anticipates first-quarter share buybacks in the range of $600 million to $700 million, following roughly $400 million repurchased in the fourth quarter. PNC held its quarterly common dividend steady at $1.70 per share, set to be paid on Feb. 5 to shareholders of record as of Jan. 20.

PNC kicked off 2026 with a 10.6% common equity tier 1 ratio, a crucial gauge of bank capital. The bank reported that average loans and deposits climbed 1% and 2%, respectively, from the previous quarter. On Jan. 5, it finalized its acquisition of FirstBank, which will boost loans and deposits in the first quarter’s numbers.

Credit remains a key focus for traders. PNC recorded a $139 million provision for credit losses—funds reserved for possible bad loans—and reported a 17% jump in delinquencies compared to the previous quarter, alongside a slight increase in total nonperforming loans.

PNC announced it will redeem all $1.25 billion of its 4.758% fixed-to-floating senior notes due 2027 on Jan. 26, paying par value plus accrued interest.

The stock closed Thursday up 1.28% at $215.04, having fluctuated between $212.42 and $216.21 during the session. How shares respond on Friday will reveal if the earnings beat can push them back to early-January territory.

The setup remains messy. A sharper fall in market rates could squeeze net interest margins, while any credit deterioration—particularly in commercial lending—would raise provisions and weigh on profits.

At 9 a.m. EST, management takes the mic for the earnings call, with investors zeroing in on 2026 net interest income projections, cost controls, and the pace of buybacks. Eyes will also be on the Jan. 26 redemption, searching for clues about funding expenses and balance-sheet strategies.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees
Previous Story

Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees

Nvidia CEO Jensen Huang shuts down “God AI” hype — and says AI will still “eat software”
Next Story

Nvidia CEO Jensen Huang shuts down “God AI” hype — and says AI will still “eat software”

Go toTop